Pfizer CEO joins host of executives at Covid-19 vaccine makers in big stock sale

Albert Bourla sold about 60% of his personal shares after positive vaccine news this week; sale’s price and volume had been authorized in a February planning move
Albert Bourla sold about 60% of his personal shares after positive vaccine news this week; sale’s price and volume had been authorized in a February planning move
The timing this week of Pfizer Inc. Chief Executive Albert Bourla’s sale of about $5.6 million in company shares—on the same day it announced positive results from its Covid-19 vaccine—is drawing scrutiny from some investors.